Macrophage migration inhibitory factor is a constitutively expressed cytokine in the human adrenal gland

IUBMB Life

Volumn 55, Issue 3, 2003, Pages 155-158

  Jian, Ming ^a   Parker, C Richard ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adrenal cortex; Immune regulator; Immunohistochemistry; Macrophage migration inhibitory factor

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADRENAL GLAND; ADULT; AGE; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA PROBE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEPHRECTOMY; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADRENAL CORTEX; ADRENAL GLANDS; ADULT; CYTOKINES; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0037794442     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/1521654031000106672     Document Type: Article

References (26)

1. George, M., and Vaughan, J. H. (1962) In vitro cell migration as a model for delayed hypersensitivity. Proc. Soc. Exp. Biol. Med. 111, 514-521.
2. Bucala, R. (1996) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB Journal 10, 1607-1613.
3. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71.
4. Waeber, G., Calandra, T., Bonny, C., and Bucala, R. (1999) A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress. Diab/Metab. Res. Rev. 15, 47-54.
5. Rosengren, E., Bucala, R., Aman, P., Jacobsson, L., Odh, G., Metz, C. N., and Rorsman, H. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2, 143-149.
6. Matsunaga, J., Sinha, D., Pannell, L., Santis, C., Solano, F., Wistow, G. J., and Wearing, V. J. (1999) Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J. Biol. Chem. 274, 3268-3271.
7. Esumi, N., Budarf, M., Ciccarelli, L., Sellinger, B., Kozak, C. A., and Wistow, G. (1998) Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mam. Genome 9, 753-757.
8. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382.
9. Paralkar, V., and Wistow, G. (1994) Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19, 48-51.
10. Magi, B., Bini, L., Liberatori, S., Marzocchi, B., Raggiaschi, R., Arcuri, F., Tripodi, S. A., Cintorino, M., Tosi, P., and Pallini, V. (1998) Charge heterogeneity of macrophage migration inhibitory factor (MIF) in human liver and breast tissue. Electrophoresis 19, 2010-2013.
11. Arcuri, F., del Vecchio, M. T., de Santi, M. M., Lalinga, A. V., Pallini, V., Bini, L., Bartolommei, S., Parigi, S., and Cintorino, M. (1999) Macrophage migration inhibitory factor in the human prostate: identification and immunocytochemical localization. Prostate 39, 159-165.
12. Arcuri, F., Cintorino, M., Vatti, R., Carducci, A., Liberatori, S., and Paulesu, L. (1999) Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol. Reprod. 60, 1299-1303.
13. Meinhardt, A., Bacher, M., Wennemuth, G., Eickhoff, R., and Hedger, M. (2000) Macrophage migration inhibitory factor (MIF) as a paracrine mediator in the interaction of testicular somatic cells. Andrologia 32, 46-48.
14. Wada, S., Fujimoto, S., Mizue, Y., and Nishihira, J. (1997) Macrophage migration inhibitory factor in the human ovary: Presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int. 41, 805-814.
15. Bacher, M., Meinhardt, A., Lan, H. Y., Mu, W., Metz, C. N., Chesney, J. A., Calandra, T., Gemsa, D., Donnelly, T., Atkins, R. C., and Bucala, R. (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150, 235-246.
16. Kobayashi, S., Satomura, K., Levsky, J. M., Sreenath, T., Wistow, G. J., Semba, I., Shum, L., Slavkin, H. C., and Kulkarni, A. B. (1999) Expression pattern of macrophage migration inhibitory factor during embryogenesis. Mech. Dev. 84, 153-156.
17. Parker, C. R. Jr, Falany, C. N., Stockard, C. R., Stankovic, A. K., and Grizzle, W. E. (1994) Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues. J. Clin. Endo. Metab. 78, 234-236.
18. Parker, C. R., Jr, Faye-Petersen, O., Stankovic, A. K., Mason, J. I., and Grizzle, W. E. (1995) Immunohistochemical evaluation of the cellular localization ontogeny of 3β-hydroxysteroid dehydrogenase/delta 5-4 isomerase in the human fetal adrenal gland. Endocr. Res. 21, 69-80.
19. Parker, C. R. Jr (1999) Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64, 640-647.
20. Parker, C. R. Jr, Stankovic, A. K., Faye-Petersen, O., Falany, C. N., Li, H., and Jian, M. (1998) Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells. Endocr. Res. 24, 669-673.
21. Baulieu, E. E. (1996) Dehydroepiandrosterone (DHEA): A fountain of youth?. J. Clin. Endo. Metab. 81, 3147-3151.
22. Araneo, B., and Daynes, R. (1995) Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 136, 393-401.
23. Longcope, C. (1995) The metabolism of dehydroepiandrosterone sulfate. Sem. Repro. Endocrinol. 13, 270-274.
24. Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., and Vinson, G. P. (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endo. Rev. 19, 101-143.
25. Koob, G. F. (1999) Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psych. 46, 1167-1180.
26. Meduri, G. U. (1999) New rationale for glucocorticoid treatment in septic shock. J. Chemotherapy 11, 541-550.